Though demanding, laboratories ought to do their finest to maintain an current listing of relevant DBZDs in their MS confirmation assays and look at whether or not these DBZDs is going to be detected on their certain immunoassay platforms.The latter group might not be at risk being an unintended aspect effect of a potential restriction on BZDs, whi